Endocrine Abstracts

Contents

• Plenary Lecturers’ Biographical Notes
• • Society for Endocrinology Dale Medal Lecture
  • • Estrogen receptor insensitivity: basic and clinical consequences in hormone and endocrine physiology

      ea0028pl1
    • Society for Endocrinology Dale Medal Lecture

      ea0028pl1biog
  • Society for Endocrinology Hoffenberg International Medal Lecture
  • • Bone as endocrine organ

      ea0028pl2
    • Society for Endocrinology Hoffenberg International Medal Lecture

      ea0028pl2biog
  • Society for Endocrinology Transatlantic Medal Lecture
  • • Joining the dots: epigenetics, metabolism and the circadian clock

      ea0028pl3
    • Society for Endocrinology Transatlantic Medal Lecture

      ea0028pl3biog
  • Society for Endocrinology European Medal Lecture
  • • Abstract unavailable

      ea0028pl4
    • Society for Endocrinology European Medal Lecture

      ea0028pl4biog
  • Society for Endocrinology Jubilee Medal Lecture
  • • Acromegaly - improving outcomes

      ea0028pl5
    • Society for Endocrinology Jubilee Medal Lecture

      ea0028pl5biog
  • British Thyroid Association Pitt-Rivers Lecture
  • • The thyroid - too much and too little across the ages

      ea0028pl6
    • British Thyroid Association Pitt-Rivers Lecture

      ea0028pl6biog
  • Society for Endocrinology Medal Lecture
  • • Genetic, molecular and physiological mechanisms involved in human obesity

      ea0028pl7
    • Society for Endocrinology Medal Lecture

      ea0028pl7biog
  • Clinical Endocrinology Trust Medal Lecture
  • • Developing growth hormone agonists and antagonists for the clinic

      ea0028pl8
    • Clinical Endocrinology Trust Medal Lecture

      ea0028pl8biog
  • Clinical Endocrinology Trust Visiting Professor Lecture
  • • Long-term outcome and quality of life in patients with disorders of sex development

      ea0028pl9
    • Clinical Endocrinology Trust Visiting Professor Lecture

      ea0028pl9biog
• Symposia
• • Genetic regulation of pituitary tumorigenesis
  • • Genetic models of pituitary disease in multiple endocrine neoplasia type 1 (MEN1)

      ea0028s1.1
    • Modelling pituitary tumours in zebrafish

      ea0028s1.2
    • A mouse model of paediatric craniopharyngioma

      ea0028s1.3
    • Molecular signatures of pituitary tumours

      ea0028s1.4
  • Endoplasmic reticulum stress in metabolic disease and obesity
  • • ER stress and metabolic regulation

      ea0028s2.1
    • Abstract unavailable

      ea0028s2.2
    • Lipotoxic endoplasmic reticulum stress and pancreatic beta cell demise in type 2 diabetes

      ea0028s2.3
    • Abstract unavailable

      ea0028s2.4
  • Testosterone in men: how long can you go?
  • • Abstract unavailable

      ea0028s3.1
    • Abstract unavailable

      ea0028s3.2
    • What is the best form of testosterone replacement therapy (TRT) ?

      ea0028s3.3
    • Can testosterone therapy be stopped in some hypogonadal patients?

      ea0028s3.4
  • Advances in the management of differentiated thyroid cancer
  • • Can imaging predict malignancy in a thyroid nodule?

      ea0028s4.1
    • Predictive value of cytology and molecular markers

      ea0028s4.2
    • Abstract unavailable

      ea0028s4.3
    • Abstract unavailable

      ea0028s4.4
  • Sprint or marathon: muscling in on the Olympics
  • • Muscles and their myokines

      ea0028s5.1
    • Exercise effects on fat metabolism and insulin sensitivity in human muscle

      ea0028s5.2
    • Molecular control of glycogen storage in muscle

      ea0028s5.3
    • Mitochondrial dysfunction and muscle disease

      ea0028s5.4
  • Inhibiting steroid enzymes to treat common diseases
  • • Ageing gracefully - the role of 11[beta]-HSD1

      ea0028s6.1
    • Old drugs for new targets - CYP11B2 inhibitors for hypertension

      ea0028s6.2
    • Dual aromatase and steroid sulphatase inhibition in breast cancer

      ea0028s6.3
    • Potential prostate cancer drug therapy targets bioactivation of androstanediol to dihydrotestosterone

      ea0028s6.4
  • Latitude: Endocrine consequences of human migration
  • • The origins and evolution of lactase persistence

      ea0028s7.1
    • Melatonin, light and sleep in the Antarctic

      ea0028s7.2
    • Cortisol and mood - coping with the seasons

      ea0028s7.3
    • Resurgence of vitamin D deficiency rickets in the UK

      ea0028s7.4
  • Small molecules, big effects: the emerging role of microRNAs
  • • How do microRNAs work?

      ea0028s8.1
    • MicroRNA regulation of the IGF axis

      ea0028s8.2
    • The regulatory role of miR-375 in the pancreatic [beta]-cell secretome

      ea0028s8.3
    • MicroRNA in the diagnosis and therapy of endocrine cancers

      ea0028s8.4
  • Developmental programming of endocrine disease
  • • Developmental programming of type 2 diabetes

      ea0028s9.1
    • Neuroendocrine programming of obesity

      ea0028s9.2
    • The fetus or the placenta? Targets of glucocorticoid programming

      ea0028s9.3
    • Obesity in pregnancy: implications for the next generation

      ea0028s9.4
  • Current concepts and management of phaeochromocytoma
  • • Genetics and epidemiology of phaeochromocytoma/paraganglioma

      ea0028s10.1
    • Molecular mechanisms of phaeochromocytoma and tumorigenesis

      ea0028s10.2
    • Phaeochromocytoma: laboratory assessment and diagnostic imaging

      ea0028s10.3
    • Novel therapies for malignant phaeochromocytoma and paraganglioma

      ea0028s10.4
  • Novel lessons form mineralocorticoid excess
  • • A difficult TASK: murine models of mineralocorticoid excess

      ea0028s11.1
    • Human Potassium channel mutations and mineralocorticoid hypertension

      ea0028s11.2
    • Long-term consequences of primary aldosteronism

      ea0028s11.3
    • New approaches to inhibition of mineralocorticoid action

      ea0028s11.4
  • Medullary thyroid cancer
  • • Molecular pathogenesis of MTC: Role of RET oncogene

      ea0028s12.1
    • RAS mutations in sporadic MTC

      ea0028s12.2
    • The diagnosis and surgical management of medullary thyroid cancer

      ea0028s12.3
    • Novel targeted therapies for MTC

      ea0028s12.4
• Clinical Management Workshops
• • The late consequences of cancer therapy in adults
  • • The follow up of cancer survivors

      ea0028cmw1.1
    • The impact of cancer treatment on pituitary function

      ea0028cmw1.2
    • Abstract unavailable

      ea0028cmw1.3
    • The late consequences of cancer therapy to the thyroid

      ea0028cmw1.4
  • Controversies in aetiology and management of osteoporosis
  • • Impact of Lifestyle Choices on Skeletal Health

      ea0028cmw2.1
    • Osteoporosis and metabolic bone disease in adolescence

      ea0028cmw2.2
    • Complications of antiresorptive agents

      ea0028cmw2.3
    • New and emerging therapies for osteoporosis

      ea0028cmw2.4
  • Advances in assessment and management of infertility
  • • Abstract unavailable

      ea0028cmw3.1
    • What's new with diagnosing sperm defects?

      ea0028cmw3.2
    • How can we predict ovarian reserve and how useful is this?

      ea0028cmw3.3
    • The Endocrine basis of what we do in the IVF Clinic

      ea0028cmw3.4
  • How do I approach...
  • • Drug-induced Hyperprolactinaemia

      ea0028cmw4.1
    • Endocrine assessment in HIV/AIDS

      ea0028cmw4.2
    • Neuroendocrine assessment in morbid obesity

      ea0028cmw4.3
    • Endocrine evaluation in a patient with coeliac disease

      ea0028cmw4.4
    • Hypogonadism in men with prostate cancer

      ea0028cmw4.5
    • Abstract unavailable

      ea0028cmw4.6
• Applied Physiology Workshop
• • Nanomedicine
  • • Abstract unavailable

      ea0028ap1.1
    • Nanoparticles for molecular imaging of angiogenesis and targeted antiangiogenic therapy

      ea0028ap1.2
    • Nanomedicine in clinical diabetes

      ea0028ap1.3
• Debate
• • (1)
  • • Debate: This house believes that all adrenal patients with incidentalomas who fail to suppress after dexamethasone should have an adrenalectomy

      ea0028d1
    • Abstract unavailable

      ea0028d2
• Meet the Expert Sessions
• • (1)
  • • Therapeutic management of adults with CAH

      ea0028mte1
    • Amiodarone

      ea0028mte2
    • Preventing and managing long term complications of acromegaly

      ea0028mte3
    • Abstract unavailable

      ea0028mte4
    • The surgical approaches to MEN1 - what the endocrinologist needs to know

      ea0028mte5
    • Prioritising therapy in neuroendocrine tumours

      ea0028mte6
    • Regulating periods and optimising fertility in PCOS

      ea0028mte7
    • Optogenetics: controlling cells with light

      ea0028mte8
    • All you need to know about ChIP-sequencing

      ea0028mte9
• Nurse Session
• • Thyroid eye disease
  • • Thyroid eye disease: diagnosis and management

      ea0028n1.1
    • Thyroid eye disease - case presentation

      ea0028n1.2
    • My thyroid eye disease journey

      ea0028n1.3
  • Addison';s/ phaeochromocytomas/Conn's Syndrome
  • • Primary hyperaldosteronism (Conn's syndrome) and phaeochromocytoma

      ea0028n2.1
    • Abstract for paraganglioma case presentation at Nurses session at 19-22 March 2012

      ea0028n2.2
    • Introduction to Addison's disease

      ea0028n2.3
    • Day -Day practice on Management of steroid replacement

      ea0028n2.4
    • Living with Addison's

      ea0028n2.5
• Young Endocrinologists Session
• • Young endocrinologists' prize lectures
  • • Challenging the dogma: Tissue specific regulation of insulin action

      ea0028yep1.1
    • Quantifying in vivo extra-adrenal cortisol production and dysregulation in human metabolic disease

      ea0028yep1.2
  • Obtaining funding and networking for young endocrinologists
  • • Abstract unavailable

      ea0028ye1.1
    • Abstract unavailable

      ea0028ye1.2
    • Career opportunities in the United States

      ea0028ye1.3
    • The trials and tribulations of a University Lecturer

      ea0028ye1.4
• Senior Endocrinologists Session
• • (1)
  • • Seeing the light

      ea0028se1.1
    • It's time to identify the hormone that controls body fat content

      ea0028se1.2
    • UK stance on adult GH replacement maintains our isolation from Europe

      ea0028se1.3
    • Assisted conception

      ea0028se1.4
    • Why does the endocrine dog not bark in the cytokine night?

      ea0028se1.5
    • Psychopathology of a false conviction

      ea0028se1.6
• Oral Communications
• • Young Endocrinologists prize session
  • • Functional characterisation and translational clinical applications of kisspeptin-10

      ea0028oc1.1
    • Structure-function analysis of calcium-sensing receptor (CaSR) mutations reveal clustering at calcium binding sites of the extracellular bilobed venus flytrap domain

      ea0028oc1.2
    • Effect of selenium status on the skeleton in post-menopausal women: the OPUS study

      ea0028oc1.3
    • The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis

      ea0028oc1.4
    • Growth Retardation and Severe Constipation due to the first human, dominant negative Thyroid Hormone Receptor Alpha mutation

      ea0028oc1.5
    • A homozygous glutathione peroxidase 1 mutation, p. Arg130-Leu133del, in a patient with Familial Glucocorticoid Deficiency

      ea0028oc1.6
    • Progressive adrenal insufficiency and 46,XY DSD caused by two novel mutations in the cytochrome P450 side-chain cleavage (CYP11A1) gene

      ea0028oc1.7
    • Metastasis related methyltransferase 1 (Merm1) /WBSCR22 regulates glucocorticoid receptor (GR) function

      ea0028oc1.8
  • Reproduction and bone
  • • The expression of kisspeptin and kisspeptin receptor is altered in pre-eclampsia

      ea0028oc2.1
    • Contrasting effects of kisspeptin-10 between men and women reveal sexual dimorphism in the hypothalamic regulation of human reproduction

      ea0028oc2.2
    • Kissorphin, a hexapeptide derivative of Kisspeptin, acts via Neuropeptide FF receptors to inhibit cyclic adenosine monophosphate release but has no Gonadotrophin-Releasing-Hormone releasing activity

      ea0028oc2.3
    • ER[beta] and GPR30 mediate distinct and opposite oestrogenic influences on microglial phagocytosis of apoptotic neuronal cells

      ea0028oc2.4
    • Nutrient regulation of growth factor signalling in human placenta

      ea0028oc2.5
    • Identification of microRNAs involved in regulating growth factor signalling in the first trimester placenta

      ea0028oc2.6
    • Increased cardiovascular events in women with Polycystic Ovary Syndrome: retrospective analysis of a large database

      ea0028oc2.7
    • A calcium-sensing receptor (CaSR) variant, Glu250Lys, present in familial hypocalciuric hypercalcaemia (FHH) and autosomal dominant hypocalcaemic hypercalciuria (ADHH) probands represents a functionally neutral polymorphism: lessons for CaSR mutational analysis

      ea0028oc2.8
  • Obesity, thyroid and Addison's disease
  • • Metformin in obese children and adolescents (MOCA) trial

      ea0028oc3.1
    • Post-prandial high fat intake leads to acute exposure to circulating endotoxin in type 2 diabetes mellitus subjects

      ea0028oc3.2
    • Risk of diabetes, cancer, large vessel disease and mortality in young women with Polycystic Ovary Syndrome: a retrospective database analysis

      ea0028oc3.3
    • Glucose absorption capacity of the mature adipose tissue is increased after Bardet-Biedl syndrome induced ciliary defect in adipocytes' precursors

      ea0028oc3.4
    • Steroidogenic function following B lymphocyte depletion therapy in new onset autoimmune Addison's disease

      ea0028oc3.5
    • GATA3 polymorphisms are associated with autoimmune Addison's disease

      ea0028oc3.6
    • Subclinical hypothyroidism is associated with fatigue and impaired functional status in males in the Whickham 20-year follow up cohort

      ea0028oc3.7
    • Dietary factors augment the ability of the proto-oncogene PBF to induce goitrogenesis and hyperplasia in vivo

      ea0028oc3.8
  • Steroid
  • • Increased 11[beta]-hydroxysteroid dehydrogenase type 1 activity is associated with the adverse expression of glucocorticoid target genes in ageing human skin

      ea0028oc4.1
    • Age-dependent increase in the expression/activity of 11[beta]-HSD1 in key metabolic tissues may underpin the ageing phenotype notably sarcopenia

      ea0028oc4.2
    • A hypomorphic H6PD allele is sufficient to rescue the skeletal myopathy but not the lack of 11[beta]-HSD type 1-mediated glucocorticoid regeneration phenotypes of H6PDKO mice

      ea0028oc4.3
    • Broad phenotypic spectrum of 17[alpha]-hydroxylase deficiency: Functional characterisation of 4 novel mutations in the CYP17A1 gene

      ea0028oc4.4
    • A novel repressor mechanism regulating fetal Leydig cell steroidogenesis, perturbation of which results in masculinization disorders

      ea0028oc4.5
    • Fatty liver in a mouse model of congenital adrenal hyperplasia is driven by peroxisome proliferator-activated receptors

      ea0028oc4.6
    • Glucocorticoids increase subcutaneous adipose tissue insulin sensitivity in vivo: a randomised double-blind, placebo controlled, cross over study

      ea0028oc4.7
    • The role of a novel co-regulator in modifying the transcriptonal activities of the glucocorticoid receptor

      ea0028oc4.8
  • Growth, tumours and pituitary
  • • Human growth is regulated by an ubiquitination pathway including CUL7, OBSL1 and CCDC8

      ea0028oc5.1
    • A network analysis of gene expression through childhood highlights changes related to age and growth

      ea0028oc5.2
    • Long term experience of 131I-MIBG therapy in the treatment of neuroendocrine tumours: has it improved survival and what are the long term sequelae?

      ea0028oc5.3
    • Steroid metabolomics in adrenocortical carcinoma reveals mitotane as an inducer of CYP3A4 and an inhibitor of 5alpha-reductase activity with major implications for drug metabolism and hydrocortisone replacement

      ea0028oc5.4
    • Role of the hypoxic signalling pathways in the histopathological prediction of malignancy in phaeochromocytomas and paragangliomas

      ea0028oc5.5
    • SUMOylation genes in pituitary gonadotrophs: wrestling with GnRH signalling

      ea0028oc5.6
    • The role of the familial pituitary adenoma gene, AIP, in the proliferative and invasive activity of a malignant pancreatic cell line

      ea0028oc5.7
    • Control of GH and IGF1 in acromegaly in the UK: Responses to medical treatment

      ea0028oc5.8
• Poster Presentations
• • Bone
  • • Epidemiology and outcomes in patients with

      ea0028p1
    • A case of HPT-JT syndrome with mutation involving exon 2 of CDC73 gene

      ea0028p2
    • Outcome of patients with negative neck exploration for primary hyperparathyroidism

      ea0028p3
    • The impact of different vitamin D preparations for the treatment of vitamin D deficiency in primary hyperparathyroidism (PTHP)

      ea0028p4
    • Bone mineral density in a clinic-based cohort of hypogonadal men

      ea0028p5
    • Recurrent pancreatitis in patient with Familial Hypocalciuric Hypercalcaemia (FHH) sucessfully treated with cinacalcet

      ea0028p6
    • Audit on the management of primary hyperparathyroidism by parathyroidectomy

      ea0028p7
    • Ostiopathia striata with cranial sclerosis.

      ea0028p8
    • A survey of current care for children & adults with osteogenesis imperfecta in glasgow

      ea0028p9
    • The use of teriparatide to treat hypoparathyroidism following thyroidectomy; a case report

      ea0028p10
    • Evaluation of the surgical management of primary hyperparathyroidism in a tertiary referral unit

      ea0028p11
    • A review of the multidisciplinary management of primary hyperparathyroidism in a district general hospital

      ea0028p12
    • Osteoporosis in healthy South Indian males: the influence of life style factors and vitamin D status

      ea0028p13
    • Unusual presentation of idiopathic hypoparathyrodism with hyper-CK-emia

      ea0028p14
    • Unusual presentation of primary hyperparathyroidism

      ea0028p15
    • A study of vitamin D status and Bone Mineral Density in epileptic patients from South India

      ea0028p16
    • Audit of pre-operative imaging in primary hyperparathyroidism

      ea0028p17
    • Hypercalcaemia secondary to granulomatous disorders- a series.

      ea0028p18
    • Efficacy of differing vitamin D supplementations, and the associated cost implications

      ea0028p19
    • Vitamin D, no longer the forbidden fruit in hypercalcaemia

      ea0028p20
    • An audit of vitamin D status among local multiple sclerosis patients

      ea0028p21
    • Lithium induced hyperparathyroidism

      ea0028p22
  • Clinical biochemistry
  • • A method for simultaneous analysis of androgens, dutasteride and finasteride in human serum by liquid chromatography tandem mass spectrometry

      ea0028p23
    • Urine steroid profiling for diagnosis of 5[alpha]-reductase type 2 deficiency

      ea0028p24
    • Differences in the measurement of cortisol in males and females

      ea0028p25
    • The effect of major surgery on glucocorticoid concentrations

      ea0028p26
    • Using the hyperaldosteronism cohort to define normative catecholamine levels for adrenal venous sampling

      ea0028p27
    • Tolvaptan for the treatment of hyponatraemia secondary to SIADH in cancer patients

      ea0028p28
    • The incidence, and impact on outcome, of hypo- and hypernatraemia in patients with spontaneous aneurysmal subarachnoid haemorrhage (SAH)

      ea0028p29
    • Testosterone measurement by mass spectrometry - a tale of three internal standards

      ea0028p30
    • An unusual case of hypocalcaemia

      ea0028p31
    • Vitamin D deficiency is associated with worsened biochemical features and poorer diagnostic accuracy in patients with primary hyperparathyroidism

      ea0028p32
    • Using salivary cortisols to aid inferior petrosal sinus sampling

      ea0028p33
    • What are the factors influencing length of stay in patients with hyponatraemia? A prospective study on an acute medical unit

      ea0028p34
    • Pseudophaeochromocytoma with clozapine

      ea0028p35
    • Hyperprolactinaemia secondary to an unusual coincidence of macroprolactin and a pituitary lesion- a case report

      ea0028p36
    • Vitamin D deficiency: What are the factors influencing severity? A retrospective cohort study in an outpatient population.

      ea0028p37
  • Clinical practice/governance and case reports
  • • The relationship between Vitamin D and HbA1C in a type 1 diabetic paediatric population

      ea0028p38
    • A UK epidemic of testosterone prescribing 2000-2010: 'Never mind the testes'

      ea0028p39
    • Hunting for the underlying cause of Cushing's syndrome

      ea0028p40
    • Low prevalence of pituitary pathology in men presenting with isolated hypogonadotrophic hypogonadism

      ea0028p41
    • Endoscopic ultrasonography is a sensitive tool in the preoperative localization of insulinoma

      ea0028p42
    • Disconnection hyperprolactinaemia in non-adenomatous sellar/parasellar lesions practically never exceeds 2000 mU/L

      ea0028p43
    • Determining the utility of the 60 minute cortisol measurement in the short synacthen test

      ea0028p44
    • A protocol for avoidance of post-thryoidectomy hypocalcaemia, results of first 12 months' audit

      ea0028p45
    • Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a 7 years period

      ea0028p46
    • Management of Vitamin D deficiency: a clinical audit of two loading regimens.

      ea0028p47
    • A comparative quality assessment of evidence-based clinical guidelines in Endocrinology

      ea0028p48
    • Abstract unavailable

      ea0028p49
    • Barts Endocrine Telephone Advice Clinic (ETAC): utilisation and outcomes from the first 18 months

      ea0028p50
    • Audit of outcome of childhood onset growth hormone deficiency in young adults at the Royal Hospital for Sick Children, Yorkhill, Glasgow from 2005-2011.

      ea0028p51
    • The cost, efficacy and safety of Omnitrope compared with Genotropin in adults with growth hormone deficiency

      ea0028p52
    • Antiphospholipid syndrome and adrenal insufficiency: a case series

      ea0028p53
    • Survey of hypercalcaemia and audit of further management with focus on primary hyperparathyroidism

      ea0028p54
    • Role of adrenal vein sampling in primary hyperaldosteronism: our experience

      ea0028p55
    • Secondary adrenal suppression and Cushing's syndrome caused by ritonavir boosted effects of inhaled fluticasone, injected triamcinolone and topical clobetasol: A case series of 11 patients.

      ea0028p56
    • DEME (Diabetes Endocrinology in Medical Education) Survey - Evaluation of Endocrinology and Diabetes teaching at a UK Medical School

      ea0028p57
    • Role of plasmapheresis in rapid pre-operative stabilisation of severe Grave's thyrotoxicosis

      ea0028p58
    • Tricky sums: The endocrine manifestations of hypoalbuminaemia

      ea0028p59
    • Case Report: Postoperative hypocalcaemia, a novel management option

      ea0028p60
    • Referral pattern & biochemical work-up of adrenal lesions and the role of endocrinologists in managing patients undergoing surgical adrenalectomy: A single centre audit of 10 years of laparoscopic adrenalectomies

      ea0028p61
    • Web-based 360-degree assessment survey to assess care and service improvement needs in an Endocrine unit

      ea0028p62
    • GLP-1 dependent hyperinsulinaemic-hypoglycaemia following partial-gastrectomy and Roux-en-Y bypass in a lean patient

      ea0028p63
    • Danazol falsely elevates oestradiol levels in a woman with ovarian failure

      ea0028p64
    • A streamlined strategy for the biochemical investigation of adrenal incidentalomas

      ea0028p65
    • Correcting hyponatraemia on the AMU: learn to walk before you can run?

      ea0028p66
    • Adrenal incidentalomas outside the Endocrinology clinic

      ea0028p67
    • Acute presentation of ectopic Cushing's syndrome due to Phaeochromocytoma co-secreting ACTH

      ea0028p68
    • An unusual case of hypercalcaemia as the presenting feature of pneumocystis jivorecii pneumonia (PCP)

      ea0028p69
    • Hypoglycaemia outbreak: a new danger on the streets?

      ea0028p70
    • Long-term remission of postmenopausal ovarian hyperandrogenism may occur following a period of gonadotropin-releasing hormone (GnRH) agonist therapy

      ea0028p71
    • We should

      ea0028p72
    • Transient thyrotoxicosis following parathyroidectomy

      ea0028p73
    • Protease inhibitor and fluconazole-induced adrenal insufficiency - a case report

      ea0028p74
    • A rare case of prolactinoma presenting with psychosis

      ea0028p75
    • Letrozole induced Hypertestosteronism

      ea0028p76
    • Haemofiltration as a treatment for severe, resistant hypercalcaemia

      ea0028p77
    • An Unusual Clinical Presentation May Indicate an Unusual Condition: Phaeochromocytoma presenting as Acute Left Ventricular Failure

      ea0028p78
    • A reversible cause of dilated cardiomyopathy

      ea0028p79
    • Renal calculi as a presenting feature in a patient with familial hypocalciuric hypercalcaemia (FHH).

      ea0028p80
    • Proton Pump Inhibitor (PPI) induced severe symptomatic Hypomagnesaemic Hypoparathyroidism

      ea0028p81
    • Ectopic parathyroid cyst presenting with parathyroid crisis

      ea0028p82
    • When is a thyroid eye not a thyroid eye?

      ea0028p83
    • Adrenal insufficiency secondary to primary adrenal lymphoma

      ea0028p84
    • Tolvaptan-cost effective treatment for hyponatraemia (SIADH in hospitalised patients)

      ea0028p85
    • Isolated HSV infection in Waterhouse-Friderichsen syndrome

      ea0028p86
    • Charge syndrome - easily missed as it presents to multiple specialties

      ea0028p87
    • High levels of patient satisfaction after introduction of a one stop thyroid lump clinic

      ea0028p88
    • Abstract unavailable

      ea0028p89
    • IGF-2 Mediated Hypoglycaemia, secondary to Adenocarcinoma of the Prostate

      ea0028p90
    • Liothyronine an effective treatment for patient with hypothyroidism and ulcerative colitis

      ea0028p91
    • The utility and impact of a joint thyroid clinic

      ea0028p92
    • Intractable nephrogenic diabetes insipidus, transient thyroiditis and hypercalcaemia complicating long term Lithium therapy

      ea0028p93
    • A case of parathyroid carcinoma presenting as primary hyperparathyroidism in a young female subsequently diagnosed with Hyperparathyroidism- Jaw Tumour Syndrome

      ea0028p94
    • Recurrent atypical adrenocorticotrophic hormone (ACTH) secreting carcinoid tumour causing Cushing's syndrome

      ea0028p95
    • Cyclical Cushing's disease in an obese patient

      ea0028p96
    • Unusual presentation, multi speciality effort and excellent outcome - A case of ovarian carcinoid

      ea0028p97
    • Audit of detection and management of adrenal incidentalomas at a district general hospital

      ea0028p98
    • A rare cause of hypokalaemia: primary hyperparathyroidism in a patient with Gitelman syndrome

      ea0028p99
    • A case of unrecognized maternal PTH resistance and severe impact on neonatal bone mineralisation

      ea0028p100
    • Audit of which better first line screening tests for Cushing's Syndrome

      ea0028p101
    • The economics of the treatment of Grave's disease; different medication regimes, a cost-benefit analysis

      ea0028p102
    • Admission and mortality patterns of endocrine-related diseases in the emergency room of a tertiary health care center in Lagos

      ea0028p103
    • In-patient insulin prescriptions: Legal? Correct? Appropriate?

      ea0028p104
    • Diagnostic dilemmas in patients presenting with large adrenal masses - 2 case reports

      ea0028p105
    • A fatal outcome of a patient with a thyroid goitre

      ea0028p106
    • Functioning cardiac paraganglioma with underlying heterozygous SDHD mutation, diagnosed following an acute myocardial infarction- A case report

      ea0028p107
    • Hypoglycaemia: a near death experience

      ea0028p108
    • Postmenopausal hirsutism: Ovarian hyperthecosis or androgen secreting adrenal tumour

      ea0028p109
    • Audit of the West of Scotland endocrine adolescent transition clinic model, RHSC Glasgow, 2008-2010

      ea0028p110
    • Asymptomatic hypercalcaemia in a hypoparathyroid patient: vitamin D toxicity or calcium alkali syndrome?

      ea0028p111
    • Intrathyroidal parathyroid carcinoma: Putting the pieces together

      ea0028p112
    • A Case Report - Primary hyperparathyroidism presenting during pregnancy

      ea0028p113
    • Tolvaptan treatment for the syndrome of inappropriate antidiuretic hormone (SIADH): a case report

      ea0028p114
    • It is not always an Addisonian Crisis

      ea0028p115
    • Hypoadrenalism following bilateral adrenal hemorrhage secondary to metastatic lung carcinoma

      ea0028p116
    • A case of posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria

      ea0028p117
    • Primary hyperparathyroidism due to ectopic parathyroid gland adenoma

      ea0028p118
    • Cushing's syndrome secondary to a thymic carcinoid tumour

      ea0028p119
    • Bacterial meningitis as first presentation of pituitary macroprolactinoma

      ea0028p120
    • T3 a life saver

      ea0028p121
    • Invasive basal skull prolactinoma with CSF rhinorrhoea and normoprolactinaemia

      ea0028p122
    • Primary adrenal lymphoma - an unusual case of hypoadrenalism with adrenal masses fluctuating in size

      ea0028p123
    • Non-compliance in a childhood cancer survivor

      ea0028p124
    • Acute kidney injury due to Addisonian crises as presentation of undiagnosed Addison's disease

      ea0028p125
    • Madam, your symptoms make no sense

      ea0028p126
    • A case of normocalcaemic hyperparathyroidism

      ea0028p127
  • Cytokines and growth factors
  • • Muscle mass maintenance in the absence of follistatin-like 3 (FSTL3), an inhibitor of myostatin

      ea0028p128
    • Circulating IGF-II concentration is associated with longitudinal increase in high density lipoprotein cholesterol in Type 2 diabetes

      ea0028p129
    • Polymorphisms of the IGFBP3 gene influence circulating IGF-II concentration in type 2 diabetes

      ea0028p130
    • Effects of long-term intermittent administration of GH on EGF signaling in liver

      ea0028p131
    • Effect of rimonabant and metformin on inflammatory cytokines in obese women with polycystic ovary syndrome

      ea0028p132
    • A role of follistatin-Like 3 (FSTL3) in cellular proliferation

      ea0028p133
  • Growth and development
  • • Growth hormone (gh)-transgenic mice exhibit gh-stat5 insensitivity associated with up-regulation of negative signaling modulators

      ea0028p134
    • Loss of annexin 1 in mice leads to reduced proliferation in the neurogenic subventricular zone

      ea0028p135
    • Maturational effects of glucocorticoids on fetal cardiomyocytes are direct and mediated by glucocorticoid receptor

      ea0028p136
    • Under-replacement with growth hormone during transition

      ea0028p137
    • More information, please! Results of a survey on men with Klinefelter's syndrome and their satisfaction with information and support from healthcare professionals

      ea0028p138
    • Comparison of injection dose force, accuracy and precision between two growth hormone disposable injection devices

      ea0028p139
  • Neoplasia, cancer and late effects
  • • Expression of Somatostatin Receptors in Phaeochromocytoma and Paragangliomas

      ea0028p140
    • Oncogenic levels of PBF aberrantly affect p53 function leading to increased genetic instability in thyroid cancer

      ea0028p141
    • Monitoring patients with succinate dehydrogenase (SDH) mutations - A single centre experience

      ea0028p142
    • Unrecognised late effects in 'lost to follow up' adult survivors of childhood cancer.

      ea0028p143
    • What is the best long-term GH assessment strategy for adult survivors of childhood acute lymphocytic leukaemia (ALL)?

      ea0028p144
    • Use of 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) in the diagnostic pathway for large adrenal lesions

      ea0028p145
    • Physiological levels of soy isoflavones inhibit the growth of oestrogen receptor [beta]-positive but not [alpha]-positive breast cancer cells

      ea0028p146
    • Lutetium-177 DOTATATE for paraganglioma refractory to conventional chemotherapy. A case report

      ea0028p147
    • Radiological diagnosis frequently precedes clinical suspicion and biochemical confirmation in phaeochromocytoma: a pilot series

      ea0028p148
    • Use of Vandetenib in metastatic medullary carcinoma of thyroid in a paediatric patient with Multiple Endocrine Neoplasia (MEN)2B

      ea0028p149
    • Extra corporeal radiotherapy - A novel therapy for Metastatic Malignant Paraganglioma

      ea0028p150
    • Biochemical screening of adrenal incidentalomas may lead to early detection of MEN2A

      ea0028p151
    • Metastatic medullary thyroid carcinoma causing Cushing's syndrome

      ea0028p152
    • Cranial diabetes insipidus and acute myeloid leukaemia

      ea0028p153
    • A case of adrenocortical cancer with cannon ball pulmonary metastasis and primary hyperaldosteronism

      ea0028p154
    • Non-Islet Cell Tumour Hypoglycaemia in a patient with recurrent meningeal haemangiopericytoma : A Case Report

      ea0028p155
    • Hypoglycaemia predating carcinomatosis-a diagnostic challenge?

      ea0028p156
  • Nursing practise
  • • Outcome of patients with Graves' disease after long-term follow-up: data from a Nurse-led Thyroid Clinic

      ea0028p157
    • Adequacy of documented evidence of education in glucocorticoid deficient patients and subsequent nurse-led initiatives

      ea0028p158
    • Evaluation of a nurse-led telephone consultation service for adults with Hyperthyroidism due to Graves' disease

      ea0028p159
    • Succession planning: preparing the endocrine specialist nurses of tomorrow

      ea0028p160
    • Changing the nursing practice regarding the administration of Zoledronic acid

      ea0028p161
    • Audit of initiation and evaluation of growth hormone treatment in adults with growth hormone deficiency

      ea0028p162
  • Obesity, diabetes, metabolism and cardiovascular
  • • Testosterone replacement therapy has beneficial effects on Cardiovascular risk factors and liver function in hypogonadal men

      ea0028p163
    • The role of metalloproteinases and their inhibitors in adipose tissue inflammation and the development of type 2 diabetes

      ea0028p164
    • Epigenetic changes in hypothalamic energy regulating pathways implicated in programming of adult offspring

      ea0028p165
    • Association between low concentration of serum sex hormone binding globulin and insulin resistance is independent of adiposity, but may be attributable to fasting insulin concentration

      ea0028p166
    • The Hepatokine Fetuin-A is increased in PCOS women. Association with metabolic syndrome and regulation by metformin

      ea0028p167
    • Cholestatic pregnancy has a gender-specific programming effect in mouse adult offspring

      ea0028p168
    • Pravastatin does not prevent macrosomia in pregnancy complicated by maternal diabetes

      ea0028p169
    • The effect of specific micronutrients on appetite

      ea0028p170
    • Arterial stiffening and increased pressure wave reflection in HIV recipients of highly active antiretroviral therapy (HAART): the influence of insulin sensitivity, adipokines and autonomic nerve function

      ea0028p171
    • Effect of secreted frizzled-related protein 2 (sFRP2) from adipose tissue on pancreatic cell function.

      ea0028p172
    • Saturated fatty acid-activated macrophage-conditioned medium activates MAP kinases and impairs insulin sensitivity in C2C12 myotubes

      ea0028p173
    • Reducing glucocorticoid action improves hyperinsulinaemia but not insulin-sensitive glucose or fatty acid turnover in patients with type 2 diabetes with and without fatty liver

      ea0028p174
    • 6q24 Transient Neonatal Diabetes Mellitus (TNDM)-16 years of data collection.

      ea0028p175
    • Expression of genes regulating mitochondrial fusion and fission in human adipose tissue are influenced by adiposity and bariatric surgery

      ea0028p176
    • The effects of bariatric surgery on the endoplasmic reticulum stress pathway in human adipose tissue

      ea0028p177
    • Ablation of Peptide YY cells in adult mice reveals a role in beta-cell maintenance

      ea0028p178
    • Heterozygosity in the leptin receptor gene predisposes to placental and fetal overgrowth

      ea0028p179
    • Circadian dietary rhythms: association with the metabolic syndrome in the 1946 British birth cohort

      ea0028p180
    • Endothelial function, the renin-angiotensin-aldosterone axis (RAAS) and hypertension: the therapeutic role of potassium supplementation

      ea0028p181
    • Testosterone Inhibits Key Enzymes of Fatty Acid Synthase and Protects Against Hepatic Steatosis in the Tfm Mouse

      ea0028p182
    • Investigation of the cellular basis of severe hypoglycaemia associated with the AKT2 p.Glu17Lys mutation

      ea0028p183
    • The adipocyte as an active source of PLA2 isoforms influenced by adiposity, depot specificity and Type 2 Diabetes Mellitus

      ea0028p184
    • Association between rs1801260 of the circadian gene CLOCK and lipid and glucose metabolism in women with Polycystic Ovary Syndrome

      ea0028p185
    • Mutations of the Chloride/Proton Antiporter, CLC-5, lead to Impaired Endosomal Acidification in Human Proximal Tubule Epithelial Cell-lines

      ea0028p186
    • Not another case of PCOS

      ea0028p187
    • Insulin degludec has a two-fold longer half-life and a more consistent pharmacokinetic profile compared with insulin glargine

      ea0028p188
    • Consumption of ground green coffee influences 11B-HSD1 activity and improves blood pressure and body composition in healthy individuals

      ea0028p189
    • Investigating the sites and mechanisms by which peripheral prokineticin 2 administration reduces food intake and body weight in mice

      ea0028p190
    • Maternal Obesity in Human Pregnancy is Associated with Altered Placental Expression of Key Genes in Fetal Growth During the First Trimester, but not at Term

      ea0028p191
    • The role of metabolic dyslipidaemia in screening for impaired glucose regulation in polycystic ovary syndrome

      ea0028p192
    • Annexin A1, an anti-inflammatory regulator, is expressed in human adipocytes

      ea0028p193
    • Dual effect of arachidonic acid on peroxisome proliferator-activated receptor [gamma] (PPAR[gamma])-dependent action in 3T3-L1 adipocytes

      ea0028p194
    • Third agents in treatment of diabetes mellitus, patient motivation and weight reduction

      ea0028p195
    • The effect of vitamin D3 supplementation on glycemic control in type 2 diabetic patients having suboptimal vitamin D level, in an open label, randomized control trial

      ea0028p196
    • Superinduction of leptin mRNA in mouse hypothalamic neurons

      ea0028p197
    • A novel genetic mutation causing MODY 1

      ea0028p198
    • Clinical and metabolic profiles of very severely obese pregnant women and their associations with birth weight

      ea0028p199
    • Salt sensitive blood pressure in glucocorticoid receptor deficient mice

      ea0028p200
    • 24-hour urinary glucocorticoid metabolites are associated with hyperinsulinaemia independent of BMI in patients with the polycystic ovary syndrome

      ea0028p201
    • Bariatric surgery and Vitamin D deficiency: Pre-operative treatment or post-operative supplementation

      ea0028p202
    • Epigenetic signature of endothelial cells and muscle tissue in the diabetic models of limb ischemia

      ea0028p203
    • Post-partum gestational diabetes management: is fasting blood glucose sufficient?

      ea0028p204
    • Circadian clock gene BMAL1 is associated with blood pressure but not autonomic function in man

      ea0028p205
    • Retention of Leukocytes in the Diabetic Wound Environment

      ea0028p206
    • Effects of Syzygium aromaticum-derived maslinic acid on blood glucose of streptozotocin induced-diabetic rats

      ea0028p207
    • Abstract unavailable

      ea0028p208
    • Expression and metabolic function of androgen receptor in mouse adipose tissue

      ea0028p209
    • High Ankle Brachial Index and its associations in South Asians

      ea0028p210
    • Effect of Testosterone on Cholesterol Synthesis and Efflux in the Liver of the Testicular Feminised (Tfm) Mouse

      ea0028p211
    • Exposure to elevated glucose prior to differentiation re-programs the cellular secretory pathway in fetal hepatocytes

      ea0028p212
    • Chronic or intermittent exposure to Oleic acid (MUFA) induces a greater NF[kappa]B activated inflammatory response than Eicosapentaenoic acid (PUFA) in differentiated human adipocytes

      ea0028p213
    • Effects of Syzygium aromaticum-derived maslinic acid on blood glucose of streptozotocin induced-diabetic rats

      ea0028p214
    • Investigation and Management of Primary Aldosteronism - A Review of Cases and Audit of Outcomes in a Tertiary Referral Centre

      ea0028p215
    • Severe Acute Mountain Sickness and Brain Natriuretic Peptide in Humans

      ea0028p216
    • Haemoglobin A1c in diagnosis of impaired glucose regulation in polycystic ovary syndrome

      ea0028p217
    • Unique roles of CRH-Rs controlling adipocyte biology and transdifferentiation

      ea0028p218
    • Metabolic profile of Type 2 diabetes Indian Patients Undergoing Coronary Artery Bypass Surgery - a Tertiary Care Centre experience

      ea0028p219
    • Regulation of Hypothalamic Resistin and FIAF gene expression by Rosiglitazone and All-Trans Retinoic Acid (ATRA)

      ea0028p220
    • Screening for Anxiety and Depression in type 2 diabetes

      ea0028p221
    • Exercise increases plasma adiponectin and bound leptin, and decreases Plasma free leptin in Overweight Young Women with Polycystic Ovary Syndrome

      ea0028p222
    • Inpatient hypoglycaemia management

      ea0028p223
    • A comparison of the neuronal populations within the nucleus tractus solitarius activated by peripheral administration of glucagon, GLP-1 and oxyntomodulin

      ea0028p224
    • Pulse wave velocity, ankle-brachial index and transient ischaemic Attack

      ea0028p225
    • Severe insulin resistance syndrome with leptin resistance

      ea0028p226
    • Evaluation of overnight dexamethasone suppression test in obese individuals

      ea0028p227
    • Lithium induced diabetes insipidus presenting with a hyperosmolar hyperglycaemic state triggered by H1N1 influenza

      ea0028p228
    • A putative role for amino acids in appetite regulation

      ea0028p229
    • Devolving diabetes care to general practice

      ea0028p230
    • Improvement in testosterone post bariatric surgery

      ea0028p231
    • Is obesity the maine cause of metabolic syndrome in Saudi female

      ea0028p232
    • A case of protamine allergy- why is immunological investigations important?

      ea0028p233
    • Renal sodium dependent glucose co-transporter 2 (SGLT2): A neoteric target for treatment of type2 diabetes mellitus

      ea0028p234
    • Hypoglycaemia documented with continuous glucose sensing in a case of

      ea0028p235
  • Pituitary
  • • Evaluation of the expression of vesicular protein (SNARE) isoforms in human pituitary adenomas

      ea0028p236
    • Management of prolactinomas during pregnancy - A survey of four canadian provinces

      ea0028p237
    • Ultrastructural changes in somatotrophs and gonadotrophs in TPit null mice

      ea0028p238
    • Mechanisms underlying termination of acute gonadotrophin-releasing hormone (GnRH)-stimulated ERK activation.

      ea0028p239
    • Transcriptional regulation of prolactin in the rat oestrous cycle

      ea0028p240
    • Can the stability of variant aryl hydrocarbon receptor interacting protein (AIP) be a marker for pathogenicity in FIPA (familial isolated pituitary adenoma)?

      ea0028p241
    • Development of a platform technology to generate long-acting protein therapeutics

      ea0028p242
    • Acute Management of Pituitary Apoplexy: Experience in 70 consecutive cases

      ea0028p243
    • Maximising the accuracy of IPSS: Validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing's disease

      ea0028p244
    • Results and challenges of genetic testing in a large familial isolated pituitary adenoma (FIPA) kindred with an R304X AIP mutation

      ea0028p245
    • High prevalence of pituitary adenomas in patients with Macroprolactinaemia and oligo-/amenorrhoea

      ea0028p246
    • A case series of corticotroph macroadenomas and Cushing's: clinical characteristics and management

      ea0028p247
    • 'Isolated acquired secondary hypogonadism' in men referred to an adult endocrine clinic

      ea0028p248
    • Observational analysis of local protocol for screening for hypoadrenalism post pituitary surgery

      ea0028p249
    • Factors affecting growth hormone (GH) replacement during transition in patients with childhood-onset GH deficiency

      ea0028p250
    • The characterisation of growth hormone-related cardiac disease with magnetic resonance imaging

      ea0028p251
    • Discordance between growth hormone and IGF1 in patients with acromegaly following recent guidelines

      ea0028p252
    • Sleep apnoea in acromegaly: a meta-analysis

      ea0028p253
    • The Pituitary Apoplexy Score (PAS) in the evaluation and management of acute pituitary apoplexy: a single centre experience from the United Kingdom

      ea0028p254
    • Ipilimumab induced hypophysitis - an evolving clinical entity

      ea0028p255
    • Pituitary regrowth following growth hormone replacement therapy.

      ea0028p256
    • Distinct signalling cascades mediate GnRH pulse frequency-dependent differential regulation of FSH[beta] transcription via CREB and ICER activation

      ea0028p257
    • Prolactin and ACTH secreting pituitary macroadenoma and cabergoline responsive Cushing's disease: a case report

      ea0028p258
    • A case of post-radiation encephalopathy following radiotherapy for pituitary adenoma

      ea0028p259
    • Ipilimumab Induced Hypophysitis presenting as SIADH

      ea0028p260
    • Improving local services: using objective measures to determine levels of psychosocial need in pituitary patients

      ea0028p261
    • Quality of life in patients with non-functioning pituitary adenoma: the Oxford experience

      ea0028p262
    • Autoimmune hypothyroidism coexisting with a TSH secreting pituitary adenoma

      ea0028p263
    • Neurosarcoidosis presenting with anterior hypopituitarism and hypothalamic syndrome

      ea0028p264
    • Cushing's disease associated with pituitary carcinoma

      ea0028p265
    • Audit of mri imaging in growth hormone deficient children

      ea0028p266
    • Potential pitfalls in the management of thyrotropinoma

      ea0028p267
    • Local v National - comparing results of a 2010 local survey on pituitary patients' satisfaction with information and support from healthcare professionals to 2008 nationwide survey data

      ea0028p268
    • A case report of hypopituitarism following recovery from cardiac arrest - a poorly recognised sequelae?

      ea0028p269
    • Recurrent hypoglycaemia in a young lady with type 1 diabetes - an unusual cause

      ea0028p270
    • An extraventricular neurocytoma in the pituitary region

      ea0028p271
    • Late onset isolated cortisol insufficiency after pituitary haemorrhage following traumatic brain injury

      ea0028p272
    • Hyperprolactinemia: A DGH experience

      ea0028p273
    • Pregnancy as a cure for a macroprolactinoma?

      ea0028p274
    • Aggressive prolactinoma treated with a large dose of dopamine agonist and radiotherapy

      ea0028p275
    • A case of hypopituitarism secondary to metastatic colonic adenocarcinoma

      ea0028p276
    • Recurrent neutropenia associated with the use of dopamine agonists

      ea0028p277
    • Abstract unavailable

      ea0028p278
  • Reproduction
  • • Dimerisation of luteinising hormone/chorionic gonadotrophin receptor (LHCGR); impact on intracellular signaling responses and ligand specificity

      ea0028p279
    • Relevance of ERK levels in acute gonadotrophin-releasing hormone (GnRH)-stimulated ERK activation

      ea0028p280
    • FSH glycosylation in women with polycystic ovary syndrome (PCOS) undergoing ovulation induction

      ea0028p281
    • The effects of di(n-butyl) phthalate (DBP) exposure on testis cell development/function in human fetal testis xenografts

      ea0028p282
    • Androgens stimulate growth of mouse preantral follicles in culture

      ea0028p283
    • FSH glycosylation in pharmaceutical gonadotrophin preparations

      ea0028p284
    • Topographical upregulation of functional prostaglandin receptors in isolated rat uterus at postpartum

      ea0028p285
    • Impact of electromagnetic field exposures in the aetiology of male infertility

      ea0028p286
    • The interrelationship between serum Luteinising Hormone (LH) and Insulin Resistance (IR) in women with Polycystic Ovary Syndrome (PCOS)

      ea0028p287
    • Genetic variants in CYP19 associated with increased aromatase activity are not associated with male hypogonadism in type 2 diabetes

      ea0028p288
    • The involvement of transcription factor NF-kB (p50/p50, p65/p65) control of ovarian cell functions

      ea0028p289
    • Uterine cell turnover in a mouse model of adenomyosis caused by congenital adrenal hyperplasia

      ea0028p290
    • Activation of the cAMP/GCM1 pathway alters differentiation of equine chorionic gonadotrophin-secreting trophoblast cells

      ea0028p291
    • Periodic exposure to exogenous testosterone is required to maintain long-term integrity of the GnRH pulse-generator in a male with atypical Kallmann syndrome

      ea0028p292
    • Prevalence of modifiable risk factors among a clinic-based cohort of secondary hypogonadal men

      ea0028p293
    • Raloxifene inhibits the expression of the endocannabinoid system in endometriotic lesions

      ea0028p294
    • Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life

      ea0028p295
    • A case series report on outcome of fertility treatment in thalassemia major patients

      ea0028p296
    • Functional evaluation of the gonadal axis - is it useful for the etiological diagnosis of hypogonadotropic hypogonadism?

      ea0028p297
    • Identifying novel relationships between salivary biomarkers and biographical health data in study of reproductive age females with and without Polycystic Ovary Syndrome (PCOS)

      ea0028p298
    • Motility of bovine mixed and sex-sorted spermatozoa incubated in physiologically normal or high-glucose media

      ea0028p299
    • An audit on investigative workup of patients with suspected secondary hypogonadism

      ea0028p300
    • The effect of mTOR inhibitors on the rabbit ovarian secretory activity

      ea0028p301
  • Steroids
  • • Reversal of age-induced dermal atrophy in 11[beta]-hydroxysteroid dehydrogenase type 1-null mice

      ea0028p302
    • Demonstration of blood pressure-independent diffuse cardiac fibrosis in Primary Aldosteronism- a cardiac MRI study

      ea0028p303
    • HSD11B1 promoter binding of the NF-[kappa]B p65 subunit in response to TNF-[alpha] suppresses 11[beta]-HSD1 expression and activity in C2C12 muscle cells

      ea0028p304
    • Ageing and social isolation increase susceptibility to anxiety in mice lacking 5[alpha]-reductase type 1

      ea0028p305
    • Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency - analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort

      ea0028p306
    • Adipose depot specific regulation of insulin signalling by glucocorticoids

      ea0028p307
    • Negative regulation of 11[beta]-HSD1 by GH in key metabolic tissues may contribute to metabolic disease in GH deficient patients

      ea0028p308
    • Modifying impact of 17-hydroxyprogesterone and sex steroids on mineralocorticoid receptor transactivation by aldosterone

      ea0028p309
    • Oxidative stress in the pathogenesis of triple a syndrome

      ea0028p310
    • Adrenal expression of the melanocortin-2-receptor and its accessory proteins during sepsis.

      ea0028p311
    • Effects of In-Utero Exposure to Endocrine Disruptors on the Ovine Fetal Adrenal Gland

      ea0028p312
    • Pomegranate juice intake enhances salivary testosterone levels and improves mood and well being in healthy men and women

      ea0028p313
    • Development of a highly sensitive and specific ultra high performance liquid chromatography tandem mass spectrometry method for the quantitation of aldosterone in human plasma

      ea0028p314
    • Suppression of adrenal cortisol metabolism by type 2 11[beta]-hydroxysteroid dehydrogenase enzyme (11[beta]HSD2) in the luteal phase of the ovine oestrous cycle

      ea0028p315
    • Impact of prenatal androgens on glucocorticoid metabolism in an ovine model of PCOS.

      ea0028p316
    • Effects of mitotane on exogenous and endogenous steroid metabolism

      ea0028p317
    • The cortisol response to hypobaric hypoxia at rest and post-exercise

      ea0028p318
    • The use of nocturnal salivary cortisol and urinary cortisol to creatinine ratio in the evaluation of cycling in patients with Cushing's syndrome

      ea0028p319
    • Use of the 250mcg short synacthen test to differentiate between patients with primary aldosteronism and essential hypertension

      ea0028p320
    • Rare variants of sialic acid acetylesterase in autoimmune Addison's disease

      ea0028p321
    • Modified-release prednisolone increases quality of life compared to standard prednisolone in patients with adrenal insufficiency

      ea0028p322
    • Mitogen mediated Gc resistance, development of model using serum shock

      ea0028p323
    • Ethanolic extract of Medicago sativa exhibits estrogen-like activity, increases serum total proteins and decreases serum total cholesterol contents in immature female rats

      ea0028p324
    • Emergency hospital admission rates in patients with adrenal insufficiency

      ea0028p325
    • Beware the mean: Addison's diagnoses may present from ages 3-85

      ea0028p326
    • Medroxyprogesterone acetate-induced Adrenal Insufficiency

      ea0028p327
    • Hypercalcaemia - A diagnostic dilemma

      ea0028p328
    • Risk of iatrogenic Cushings syndrome and adrenal suppression in antiretroviral regimes including CYP450 3A4 inhibitors

      ea0028p329
    • Isolated Hypoaldosteronism - management challenge during pregnancy: a case report

      ea0028p330
    • Life, Death and Modern technology

      ea0028p331
    • Bilateral adrenal enlargement with Hypoadrenalism

      ea0028p332
    • Recovery of the HPA axis after Prolonged Exogenous Steroids - Experience with Three Cases

      ea0028p333
    • Regulation of de novo lipogenesis in human liver by 5[alpha]-reductase

      ea0028p333A
  • Thyroid
  • • PBF is a novel regulator of the thyroid hormone transporter MCT8

      ea0028p334
    • Successful treatment of hyperthyroidism is associated with significant risks of becoming overweight or obese

      ea0028p335
    • Management of thyroid dysfunction in pregnant women in tayside, scotland: the thyroid epidemiology, audit and research study (Tears)

      ea0028p336
    • Higher thrombus burden in patients with subclinical hypothyroidism after non ST elevation acute coronary syndrome

      ea0028p337
    • PBF interacts with cortactin and thyroglobulin in thyroid cells

      ea0028p338
    • The PI3K and HIF pathways promote radio-resistance in thyroid-carcinoma

      ea0028p339
    • Targeted hPTTG overexpression in vivo reduces thyroidal growth and thyroid cell proliferation.

      ea0028p340
    • The negative psycho-social impact of moderately active Thyroid Eye Disease

      ea0028p341
    • Orbital decompression for graves' orbitopathy in england

      ea0028p342
    • Evaluation of adjuvant lithium treatment in patients receiving radioactive iodine for hyperthyroidism: a retrospective cohort study

      ea0028p343
    • Second course of anti-thyroid treatment may be suitable for some individuals with relapsed Graves' disease.

      ea0028p344
    • Outcome after thyroid surgery - patients' perspective

      ea0028p345
    • Investigation of thyroglobulin antibody assay discordance

      ea0028p346
    • Rheumatoid Factor interference in TSH assays

      ea0028p347
    • Post-radioiodine management of patients with Graves' disease

      ea0028p348
    • Audit of radioiodine in management of benign multinodular goitres at norfolk and Norwich university hospitals

      ea0028p349
    • TSHoma: a heterogeneous condition requiring multidisciplinary management.

      ea0028p350
    • TBII at discontinuation of ATD therapy as a predictor of relapse of hyperthyroidism in Graves' disease - a prospective analysis

      ea0028p351
    • Direct access thyroid ultrasound for general practice - clinical indications and frequency of thyroid function assessment prior to making request

      ea0028p352
    • Does quantitative measurement of radioiodine (RAI) uptake on the post-high dose RAI whole body scan (WBS) predict residual disease in thyroid cancer following total thyroidectomy?

      ea0028p353
    • Unexpectedly low Thy3 rates in a dedicated one stop thyroid lump clinic

      ea0028p354
    • Unusual cause of elevated TSH levels in a treated primary hypothyroidism

      ea0028p355
    • The long-term management of thyrotoxicosis with antithyroid drugs

      ea0028p356
    • Five-year review of the management of Graves' thyrotoxicosis

      ea0028p357
    • Assessment of surgical and histological outcome of grade THY3 thyroid fine needle aspiration cytology

      ea0028p358
    • Hypothyroidism treated with intramuscular thyroxine injections

      ea0028p359
    • Predicting risk of relapse following thionamide withdrawal in Graves' disease

      ea0028p360
    • Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease

      ea0028p361
    • Hyperthyroidism in Children 5-18 years age. Review of results

      ea0028p362
    • The number of positive lymph nodes in the central compartment has no prognostic impact in papillary thyroid cancer

      ea0028p363
    • Acute deterioration in Grave's opthalmopathy following total thyroidectomy

      ea0028p364
    • Secondary hypothyroidism with silent thyroiditis - A Case Report

      ea0028p365
    • To evaluate the efficacy of radioiodine treatment for thyrotoxicosis (555 MBq)

      ea0028p366
    • Fixed drug eruption in the endocrine clinic: rare presentation of reaction to carbimazole

      ea0028p367
    • An audit on the management of hypothyroidism in pregnancy

      ea0028p368
    • Management of persistent TSH elevation in hypothyroid patients

      ea0028p369
    • Acute bulbar palsy in association with Graves thyrotoxicosis

      ea0028p370
    • Audit of the management of hypothyroidism in pregnancy: the importance of early testing to optimise treatment

      ea0028p371
    • Langerhans cell histiocytosis and Graves' disease

      ea0028p372
    • Testicular choriocarcinoma: a rare case of thyrotoxicosis arising as a paraneoplastic syndrome

      ea0028p373
    • A rare case of periodic hypokalaemic paralysis secondary to Graves' thyrotoxicosis

      ea0028p374
    • Hypercalcaemia and weight loss does not always equal malignancy

      ea0028p375
    • Comparison of existing practice of FNA cytology in thyroid nodules against the standards

      ea0028p376
    • Radioiodine treatment for thyrotoxicosis in a district hospital: An audit and patient satisfaction survey

      ea0028p377
    • The spectrum of presentations of hypothyroidism in primary care

      ea0028p378
    • 'Resistant' hypothyroidism - rare causes to consider

      ea0028p379
    • This study is aimed to evaluate the significance of various clinical and demographic factors in predicting response to radioiodine treatment for thyrotoxicosis (555 MBq)

      ea0028p380
    • Alemtuzamab induced thyrotoxicosis

      ea0028p381
    • Removal of heterophilic antibody interference in thyroid function tests with heterophilic blocking tubes

      ea0028p382
    • A case of hyperthyroidism presenting with cholestasis

      ea0028p383
    • Audit of one stop thyroid nodule clinic

      ea0028p384
    • T4 mono-therapy versus T4/T3 combination therapy: a local review

      ea0028p385